Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
Abstract Background Coronavirus disease 2019 (COVID-19) has killed over 2.5 million people worldwide, but effective care and therapy have yet to be discovered. We conducted this analysis to better understand tocilizumab treatment for COVID-19 patients. Main text We searched major databases for manus...
Saved in:
Main Authors: | Qiu Wei (Author), Hua Lin (Author), Rong-Guo Wei (Author), Nian Chen (Author), Fan He (Author), Dong-Hua Zou (Author), Jin-Ru Wei (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis
by: Jin Zhang, et al.
Published: (2023) -
Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
by: Rania M. Sarhan, et al.
Published: (2022) -
Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020) -
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
by: Tiantian Hua, et al.
Published: (2024) -
Effect of Shenling Baizhu powder on immunity to diarrheal disease: A systematic review and meta-analysis
by: Qian Chen, et al.
Published: (2022)